Table 2.

Data about the devices of the oscillating platform, the subjects, the frequency, and the amplitude used in the oscillating platforms.

Reference	Subjects (sex, age, groups)	Platform manufacturer	Oscillation frequency/amplitude	Disability level of the subjects
Schuhfried et al., [29]	Two groups: intervention (1 male/5 female, 49.3 y) and placebo (2 male/4 female, 46.0 y)	Zeptor: Med system (Scisen GmbH, Germany)	From 1 Hz/3 mm until the patient does not tolerate a further increase.	Subjects with an impairment of ≤5 based on Kurtzke's expanded disability status scale (EDSS).
Jackson et al., [30]	15 subjects (3 male/12 female, 54.6 y) were divided in two groups. A group was submitted to 2 Hz and the other one was submitted to 26 Hz	Maxuvibe platform (Fitgroup BV, Hoogstraat, Holland)	2 or 26 Hz/6 mm	Subjects with an impairment of ≤6.5 based on Kurtzke's EDSS.
Schyns et al., [31]	Two groups: Group I (5 females/3 males, 45.8 years old) and Group II (7 females/1 male, 49.5 years old)	VibroGym International BV, The Netherlands	40 Hz/2 mm	Subjects with an impairment between 1 and 6 on the Hauser ambulation index
Wunderer et al., [32]	3 subjects	VibroGym apparatus (Professional model, ES Haarlem, The Netherlands)	40 Hz/2 mm	Scores in the disease steps scale of the subjects were 2 with abnormal gait, no need for walking aid, 4 depend on unilateral support, and 5 need for bilateral support.
Broekmans et al., [28]	Two groups: WBV group (7 females/4 males, 46.1 years old) and Control group (11 females/3 male, 49.7 years old)	Alpha Vibe Nijverdal, The Netherlands	25–45 Hz/2.5 mm	Subjects with an EDSS score ranging from 1.5 to 6.5